Home » Topics » Gilead Sciences

U.S. approves new once-a-day pill to treat HIV

WASHINGTON — A new pill to treat HIV infection — combining two previously approved drugs plus two new ones — has been approved for adults living with the virus that causes AIDS, US regulators said Monday. The single daily dose of Stribild provides a complete treatment regimen for HIV infection,…

U.S. debates recommending drug for AIDS prevention

US health advisors are poised to decide Thursday on whether to recommend the drug, Truvada, as the first preventive pill against AIDS instead of just a treatment for infected people. Landmark study results published in 2010 showed that the drug, made by California-based Gilead Sciences, helped ward off HIV in…